Alerts will be sent to your verified email
Verify Email
INDOCO
|
Indoco Remedies
|
Panacea Biotec
|
Novartis
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.94 % | 17.16 % | 8.0 % |
|
5yr Avg Net Profit Margin
|
5.41 % | 19.26 % | 17.12 % |
|
Price to Book
|
2.41 | 3.06 | 2.94 |
|
P/E
|
0.0 | 222.38 | 22.42 |
|
5yr Avg Cash Conversion Cycle
|
35.3 Days | -102.87 Days | -23.33 Days |
|
5yr Average Interest Coverage Ratio
|
7.53 | 2.9 | 65.43 |
|
5yr Avg ROCE
|
13.6 % | -1.68 % | 5.91 % |
|
5yr Avg Operating Profit Margin
|
14.97 % | -1.99 % | 15.15 % |
|
5 yr average Debt to Equity
|
0.49 | 0.05 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | -64.03 % | 37.01 % |
|
5yr Average Return on Assets
|
5.31 % | 6.95 % | 3.13 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
58.9 % | 72.48 % | 70.68 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.21 % | -1.11 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.16 % | 0.0 | 0.0 |
|
Indoco Remedies
|
Panacea Biotec
|
Novartis
|
|---|